Physician profile
Joe B Proctor
NPI 1205129582
$3,029.64
in general payments reported to CMS, 2019-2025
34 companies · $567 in 2025
The $567 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $241 · 2021: $480 · 2022: $231 · 2023: $446 · 2024: $626 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,638.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $362.20 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $347.62 | 2019-2025 | Mounjaro, Jardiance |
| Amgen INC. | $330.75 | 2021-2025 | Repatha, Repatha, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $272.42 | 2019-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $151.48 | 2020-2021 | |
| Abbvie INC. | $143.83 | 2021-2025 | |
| Reapplix INC. | $120.50 | 2024 | 3c Patch Kit - Box |
| Novo Nordisk INC | $113.66 | 2019-2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $113.28 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.19 | 2019-2025 | Jardiance |
| Allergan, INC. | $78.14 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $74.36 | 2019-2021 | |
| Smith+Nephew, INC. | $68.37 | 2020-2021 | |
| Glaxosmithkline, LLC. | $65.41 | 2019-2025 | Trelegy Ellipta |
| Corium, LLC | $64.81 | 2023-2025 | Azstarys |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $62.65 | 2022-2023 | Quviviq |
| Exact Sciences Corporation | $60.94 | 2024-2025 | Cologuard Collection Kit |
| Ardelyx, INC. | $55.49 | 2024-2025 | Ibsrela |
| Pfizer INC. | $52.20 | 2021-2025 | |
| Abbott Laboratories | $49.94 | 2021-2024 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $45.88 | 2023 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $44.55 | 2022-2025 | |
| Amarin Pharma, INC. | $35.56 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.45 | 2023 | Xifaxan, Trulance |
| Dexcom, INC. | $27.91 | 2021-2024 | Dexcom G6 Transmitter |
| Convatec INC. | $24.62 | 2024 | |
| Corcept Therapeutics | $24.46 | 2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $16.44 | 2019 | |
| Phathom Pharmaceuticals, INC. | $15.92 | 2023 | Voquezna |
| Kci USA, INC. | $15.52 | 2019 | |
| Ironwood Pharmaceuticals, INC | $14.25 | 2024 | |
| Horizon Therapeutics Plc | $12.50 | 2019 | |
| Currax Pharmaceuticals LLC | $11.71 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $8.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Proctor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.